STOCK TITAN
  1. Home
  2. Sec-filings
  3. NEO
  4. [SCHEDULE 13G/A] NeoGenomics, Inc. SEC Filing

[SCHEDULE 13G/A] NeoGenomics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock NEO logo
Neogenomics Inc

NASDAQ:NEO

NEO Rankings

#2596 Ranked by Market Cap
N/A Ranked by Dividends

NEO Latest News

Aug 29, 2025
Court Rules for NeoGenomics in Patent Infringement Lawsuit Against Natera
Jul 30, 2025
NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy
Jul 29, 2025
NeoGenomics Reports Second Quarter 2025 Results
Jul 1, 2025
NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
Jun 30, 2025
NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care

NEO Latest SEC Filings

Sep 3, 2025
[Form 4] NeoGenomics, Inc. Insider Trading Activity
Aug 14, 2025
[SCHEDULE 13G] NeoGenomics, Inc. SEC Filing
Aug 13, 2025
[SCHEDULE 13G] NeoGenomics, Inc. SEC Filing
Aug 8, 2025
[8-K] NeoGenomics, Inc. Reports Material Event
Aug 6, 2025
[Form 4] NeoGenomics, Inc. Insider Trading Activity

NEO Stock Data

1.16B
127.51M
1.29%
100.33%
4.05%
Diagnostics & Research
Services-testing Laboratories
Link
United States
FORT MYERS